Chinese university launches probe into girl’s gene-editing death
By John Travis,
Science
| 07. 27. 2026
Shanghai Jiao Tong University School of Medicine over the weekend said it would launch a “comprehensive investigation” into the previously undisclosed death last year of a 6-year-old girl who had received an experimental gene therapy from one of its scientists. The medical school promised “serious action” based on its findings.
Science and Retraction Watch reported the March 2025 fatality in an investigative news story last week that raised questions about the efficacy and safety of the so-called base-editing treatment, meant to fix a genetic mutation that impaired the girl’s brain development. The parents of the girl, given the pseudonym Mei, provided documents related to the trial, including a report on a primate study that showed the treatment had caused serious organ damage in four monkeys. The parents also shared financial information and recordings of conversations with her biomedical team indicating they had paid more than $860,000 for the development of the potential therapy.
The genetic recipe for the base editor was delivered into Mei’s brain cells by trillions of viruses infused into her spinal fluid. The viruses sparked a fatal...
Related Articles
What We Inherit by Sam Trejo and Daphne O. Martschenko; and Original Sin by Kathryn Paige Harden have a great deal in common, with substantial differences in style and emphasis. Both books attempt, in different ways, to show the reader just where current research into human genomics stands, where that might be going, and why the authors are interested. In short, the influence of genomic research on our societies is already large and seems likely to change them in ways...
By Dan Falk, Nautilus | 08.20.2026
The pseudoscience of eugenics, founded on the mistaken notion that nature envisions some “right” combination of genes, and that selective breeding can improve the human race, is making a comeback. While the heyday of eugenics was a century ago, the...
By Emily Packard Dawson and Lainie Friedman Ross, MedPage Today | 08.18.2026
Few things evoke a greater sense of desperation than a parent seeking an experimental treatment for their child. That desperation can make even extraordinary risks seem worth taking. This dynamic has come into stark relief after Mei, a 6-year-old girl...
By Ryan Cross, Endpoints News | 08.20.2026
China’s cheap, fast and quiet system for testing cutting-edge medicines is facing scrutiny after the deaths of three people in investigator-initiated trials.
The studies, also known as IITs, allow experimental cell and gene therapies to be tested without oversight from...